Functional activity of natural antibody is altered in Cr2-deficient mice

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5433-5440

  Reid, Russell R ^a   Woodcock, Sean ^a   Shimabukuro Vornhagen, Alexander ^a   Austen Jr , William G ^a   Kobzik, Lester ^a   Zhang, Ming ^a   Hechtman, Herbert B ^a   Moore Jr , Francis D ^a   Carroll, Michael C ^a  

^a CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B LYMPHOCYTE RECEPTOR; CD5 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M ANTIBODY; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0037111482     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5433     Document Type: Article

References (59)

1. Boyden, S. V. 1966. Natural antibodies and the immune response. Adv. Immunol. 5:1.
2. Avrameas, S. 1991. Natural autoantibodies: From "horror autotoxicus" to "gnothi seauton." Immunol. Today 12:154.
3. Tomer, Y., and Y. Shoenfeld. 1988. The significance of natural autoantibodies. Immunol. Invest. 17:389.
4. Lutz, H. U., M. Nater, and P. Stammler. 1993. Naturally occurring anti-band 3 antibodies have a unique affinity for C3. Immunology 80:191.
5. Cohen, I., and A. Cooke. 1986. Natural autoantibodies might prevent autoimmune disease. Immunol. Today 7:363.
6. Ehrenstein, M. R., H. T. Cook, and M. S. Neuberger. 2000. Deficiency in serum immunoglobulin IgM predisposes to development of IgG autoantibodies. J. Exp. Med. 191:1253.
7. Boes, M., T. Schmidt, K. Linkemann, B. C. Beaudette, A. Marshak-Rothstein, and J. Chen. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97:1184.
8. Carroll, M. C., and A. P. Prodeus. 1998. Linkages of innate and adaptive immunity. Curr. Opin. Immunol. 10:36.
9. Boes, M., C. Esau, M. B. Fischer, T. Schmidt, M. Carroll, and J. Chen. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160:4776.
10. Briles, D. E., M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J. Exp. Med. 153:694.
11. Reid, R. R., A. P. Prodeus, W. Khan, T. Hsu, F. S. Rosen, and M. C. Carroll. 1997. Endotoxin shock in antibody-deficient mice: Unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J. Immunol. 159:970.
12. Baumgarth, N., O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are non-redundant components of the protective response to influenza virus infection. J. Exp. Med. 192:271.
13. Qin, X. F., S. Schwers, W. Yu, F. Papavasiliou, H. Suh, A. Nussenzweig, K. Rajewsky, and M. C. Nussenzweig. 1999. Secondary V(D)J recombination in B-1 cells. Nature 397:355.
14. + B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today 10:364.
15. Kantor, A. B., and L. A. Herzenberg. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11:501.
16. + B cells. Immunol. Rev. 137:91.
17. +) B cells that recognize phosphatidyl choline. J. Exp. Med. 169:1869.
18. Engel, P., L. J. Zhou, D. C. Ord, S. Sato, B. Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
19. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352.
20. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283.
21. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467.
22. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470.
23. Krop, I., A. R. de Fougerolles, R. R. Hardy, M. Allison, M. S. Schlissel, and D. T. Fearon. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:238.
24. Arnold, L. W., C. A. Pennell, S. K. McCray, and S. H. Clarke. 1994. Development of B-1 cells: Segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179:1585.
25. Hayakawa, K., M. Asano, S. A. Shinton, M. Gui, D. Allman, C. L. Stewart, J. Silver, and R. R. Hardy. 1999. Positive selection of natural autoreactive B cells. Science 285:113.
26. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
27. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
28. Croix, D. A., J. M. Ahearn, A. M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M. C. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857.
29. Carroll, M. C. 2000. The role of complement in B cell activation and tolerance. Adv. Immunol. 74:61.
30. Guinamard, R., M. Okigaki, J. Schlessinger, and J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1:31.
31. Hasegawa, M., M. Fujimoto, J. C. Poe, D. A. Steeber, and T. F. Tedder. 2001. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol. 167:3190.
32. Molina, H., T. Kinoshita, K. Inoue, J. C. Carel, and V. M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: Evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145:2974.
33. Kurtz, C. B., E. O'Toole, S. M. Christensen, and J. H. Weis. 1990. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:3581.
34. Fearon, D. T., and M. C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393.
35. -/- mice: Enhanced affinity maturation but impaired antibody persistence. J. Immunol. 164:4522.
36. -/- mice is rescued by adjuvants without improvement in germinal center development. J. Immunol. 165:3119.
37. Fang, Y., C. Xu, Y. X. Fu, V. M. Holers, and H. Molina. 1998. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:5273.
38. Carter, R. H., and D. T. Fearon. 1992. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
39. Fischer, M. B., M. Ma, N. C. Hsu, and M. C. Carroll. 1998. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J. Immunol. 160:2619.
40. Weiser, M. R., J. P. Williams, F. D. Moore, Jr., L. Kobzik, M. Ma, H. B. Hechtman, and M. C. Carroll. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:2343.
41. Williams, J. P., T. T. Pechet, M. R. Weiser, R. Reid, L. Kobzik, F. D. Moore, Jr., M. C. Carroll, and H. B. Hechtman. 1999. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86:938.
42. Kilgore, K. S., R. F. Todd, and B. R. Lucchesi. 1999. Reperfusion injury. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin and R. Snyderman, eds. Lippincott, Williams, and Wilkins, Philadelphia, p. 1047.
43. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. Marsh, Jr., G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. 1990. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146.
44. Hill, J., T. F. Lindsay, F. Ortiz, C. G. Yeh, H. B. Hechtman, and F. D. Moore, Jr. 1992. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J. Immunol. 149:1723.
45. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
46. Kobzik, L., D. S. Bredt, C. J. Lowenstein, J. Drazen, B. Gaston, D. Sugarbaker, and J. S. Stamler. 1993. Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 9:371.
47. + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17:521.
48. + (CD5) B cells that recognize phosphatidyl choline: Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Exp. Med. 168:687.
49. H genes expressed in innate antibodies are associated with distinctive antigen-binding sites. Proc. Natl. Acad. Sci. USA 96:2262.
50. Eror, A. T., A. Stojadinovic, B. W. Starnes, S. C. Makrides, G. C. Tsokos, and T. Shea-Donohue. 1999. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin. Immunol. 90:266.
51. Wada, K., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 120:126.
52. Rehrig, S., S. D. Fleming, J. Anderson, J. M. Guthridge, J. Rakstang, C. E. McQueen, V. M. Holers, G. C. Tsokos, and T. Shea-Donohue. 2001. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J. Immunol. 167:5921.
53. Austen, W. G., Jr., C. Kyriakides, J. Favuzza, Y. Wang, L. Kobzik, F. D. Moore, Jr., and H. B. Hechtman. 1999. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 126:343.
54. Lazar, H. L., T. Hamasaki, Y. Bao, S. Rivers, S. A. Bernard, and R. J. Shemin. 1998. Soluble complement receptor type 1 limits damage during revascularization of ischemic myocardium. Ann. Thorac. Surg. 65:973.
55. Huang, J., L. J. Kim, R. Mealey, H. C. Marsh, Jr., Y. Zhang, A. J. Tenner, E. S. Connolly, Jr., and D. J. Pinsky. 1999. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285:595.
56. Fleming, S. D., T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers. 2002. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169:2126.
57. Epstein, J., Q. Eichbaum, S. Sheriff, and R. A. Ezekowitz. 1996. The collectins in innate immunity. Curr. Opin. Immunol. 8:29.
58. Xu, Y., M. Ma, G. C. Ippolito, H. W. Schroeder, Jr., M. C. Carroll, and J. E. Volanakis. 2001. Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. USA 98:14577.
59. Kinoshita, T., G. Thyphronitis, G. C. Tsokos, F. D. Finkelman, K. Hong, H. Sakai, and K. Inoue. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:651.